CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 281 filers reported holding CYTOKINETICS INC in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $282 | +5.2% | 8,069 | +0.2% | 0.01% | 0.0% |
| Q2 2023 | $268 | -5.6% | 8,050 | -0.5% | 0.01% | -14.3% |
| Q1 2023 | $284 | -23.2% | 8,089 | +0.2% | 0.01% | -22.2% |
| Q4 2022 | $370 | -99.9% | 8,070 | -1.5% | 0.01% | -18.2% |
| Q3 2022 | $397,000 | +31.5% | 8,190 | +6.4% | 0.01% | +37.5% |
| Q2 2022 | $302,000 | +4.1% | 7,700 | -2.2% | 0.01% | +33.3% |
| Q1 2022 | $290,000 | -19.0% | 7,870 | +0.3% | 0.01% | -25.0% |
| Q4 2021 | $358,000 | -37.6% | 7,850 | -51.1% | 0.01% | -38.5% |
| Q3 2021 | $574,000 | +80.5% | 16,050 | -0.2% | 0.01% | +85.7% |
| Q2 2021 | $318,000 | -14.3% | 16,080 | +0.8% | 0.01% | -22.2% |
| Q1 2021 | $371,000 | +16.3% | 15,950 | +4.0% | 0.01% | +12.5% |
| Q4 2020 | $319,000 | +2.6% | 15,340 | -28.5% | 0.01% | 0.0% |
| Q3 2017 | $311,000 | 0.0% | 21,460 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $311,000 | – | 21,460 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,989,218 | $47,348,000 | 10.09% |
| EcoR1 Capital, LLC | 2,139,697 | $20,306,000 | 8.01% |
| Healthcare Value Capital, LLC | 100,000 | $949,000 | 1.15% |
| DAFNA Capital Management LLC | 150,000 | $1,424,000 | 1.13% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 151,106 | $1,434,000 | 1.07% |
| Avoro Capital Advisors LLC | 503,900 | $4,782,000 | 1.06% |
| ACUTA CAPITAL PARTNERS, LLC | 140,969 | $1,338,000 | 0.64% |
| Iguana Healthcare Management, LLC | 150,000 | $1,424,000 | 0.58% |
| WASATCH ADVISORS LP | 1,746,096 | $16,570,000 | 0.25% |
| Virtus ETF Advisers LLC | 29,379 | $279,000 | 0.21% |